IQVIA™ Real-World Insights Bibliography

Cost-effectiveness of de-escalation from micafungin versus escalation from fluconazole for systemic candida infections in China
Author(s): Dechang Chen, Xianyao Wan, Eliza Kruger, Can Chen, Xiaomeng Yue, Liang Wang, Jiuhong Wu
Affiliations(s): IQVIA, Department of Critical Care Medicine, Shanghai Ruijin Hospital Affiliated To Jiaotong University, School of Medicine, Shanghai
Publication(s):  Journal of Medical Economics
Document Type(s): Article,
Countries: China,
Click here for the abstract
C:
Y:
Health economics, Infectious disease,
2018
  L:
A:
English
Cost effectiveness,
  Add to report
 
 
Profiling and treatment patterns in NSCLC patients with CNS (brain) metastases in Europe and Asia
Author(s): Mari E1, Mpima S2, Guglielmetti F1, Nasuti P2, Manuguid F2, Heitner Enschede S3
Affiliations(s): 1IQVIA , Milan, Italy 2IQVIA , London, UK 3IQVIA Inc, USA
Publication(s): 
Document Type(s): 
Countries: China, France, Germany, Italy, Japan, South Korea, Spain, UK,
Click here for the abstract
C:
Y:

2018
  L:
A:
English
  Add to report
 
 
Patterns of care and of biomolecular characterization of Right, Transverse, and Left Colorectal Cancer from real-life evidence in Asia Pacific and European countries
Author(s): Ettore M1, Mpima S2, Guglielmetti F1, Nasuti P2
Affiliations(s): 1IQVIA , Milan, Italy 2IQVIA , London, UK
Publication(s):  ESMO 2018
Document Type(s): Poster,
Countries: China, France, Germany, Italy, Japan, South Korea, Spain, UK,
Click here for the abstract
C:
Y:
Oncology,
2018
  L:
A:
English
  Add to report
 
 
The health economic impact of optimizing post-hospitalization management for an exacerbation in COPD patients in China.
Author(s): Salem A1, Ramos M1, Hu H2, Zhong H3, Lamotte M1
Affiliations(s): 1 IQVIA, Zaventem, Belgium 2 University of Macau, Macau, China 3 AstraZeneca, Shanghai, China
Publication(s): 
Document Type(s): Poster,
Countries: China,
Click here for the abstract
C:
Y:
Health economics, Respiratory disease,
2018
  L:
A:
English
Cost analysis, Cost effectiveness,
  Add to report
 
 
The health economic impact of optimizing post-hospitalization management for an exacerbation in COPD patients in China.
Author(s): Salem A, Ramos M, Hu H, Zhong H, Lamotte M
Affiliations(s): IQVIA, Zaventem, Belgium
Publication(s):  ISPOR Asia Pacific, 2018, September 8-11, Tokyo, Japan
Document Type(s): Poster,
Countries: China,
C:
Y:
Health economics, Respiratory disease,
2018
  L:
A:
English
Cost effectiveness,
  Add to report
 
 
Patterns of Therapy in Regional Lymph Node Positive Prostate Cancer in Europe and Asia: An International Analysis
Author(s):  Prentice M1, Mpima S2, Martinez de Pinillos A2, Nasuti P2, Davda R, Payne H 1
Affiliations(s): 1 University College Hospital, London, UK 2 IQVIA , London, UK
Publication(s):  ESMO 2018
Document Type(s): Poster,
Countries: China, France, Germany, Italy, Japan, South Korea, Spain, UK,
Click here for the abstract
C:
Y:
Oncology,
2018
  L:
A:
English
  Add to report
 
 
Initial Management of localised prostate cancer in the Elderly: An International Data Review
Author(s): Prentice M1, Mpima S2, Martinez de Pinillos A2, Nasuti P2, Davda R1, Payne H1
Affiliations(s): 1 University College Hospital, London, UK 2 IQVIA , London, UK
Publication(s):  SIOG 2018
Document Type(s): Poster,
Countries: China, France, Germany, Italy, Japan, South Korea, Spain, UK,
C:
Y:
Oncology,
2018
  L:
A:
English
  Add to report
 
 
Profiling and treatment patterns in NSCLC patients with CNS (brain) metastases in Europe and Asia
Author(s): Mari E1, Mpima S2, Guglielmetti F1, Nasuti P2, Manuguid F2, Heitner Enschede S3
Affiliations(s): 1IQVIA , Milan, Italy 2IQVIA , London, UK 3IQVIA Inc, USA
Publication(s):  JCO ( ASCO 2018)
Document Type(s): Abstract,
Countries: Asia Pacific, China, Europe, France, Germany, Italy, Japan, South Korea, Spain, UK,
Click here for the abstract
C:
Y:
Oncology,
2018
  L:
A:
English
  Add to report
 
 
Assessing the economic burden of type 2 diabetes in China reflecting the current standard of the disease management and for improved management scenarios using a modeling approach.
Author(s): Foos V1, Lamotte M1, McEwan P4, Jiang X3, Zhang YL3, Qu S2, De Moor R1, Ramos R1, Xiong T2, Wang K3
Affiliations(s): 1 IMS Health, Brussels, Belgium 2 IMS Health, Shanghai, China 3 Eli Lilly, Shanghai, China 4 Swansea University, Wales
Publication(s):  22nd ISPOR Annual International Meeting, 2017, May 20-24, Boston, MA, USA
Document Type(s): Abstract,
Countries: China,
C:
Y:
Diabetes,
2017
  L:
A:
English
Cost effectiveness,
  Add to report
 
 
THE ANALYSIS OF INPATIENTS COST OF BREAST CANCER IN CHINA, 2011
Author(s): Song S, Wang Z, Zhang M
Affiliations(s): IMS consulting group, Shanghai, China
Publication(s):  ISPOR 18th Annual European Congress Milan, Italy November, 2015
Document Type(s): Poster,
Countries: China,
C:
Y:
Mental health, Oncology,
2015
  L:
A:
English
  Add to report
 
 
 1 of 3 Next Page Last Page